Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Mettler-Toledo (MTD) to $1,425 from $1,515 and keeps an Outperform rating on the shares as part of the firm’s medical technology and life science tools Q1 preview.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Mettler-Toledo upgraded to Buy from Hold at Jefferies
- Mettler-Toledo price target lowered to $1,475 from $1,550 at Morgan Stanley
- Mettler-Toledo price target raised to $1,445 from $1,444 at Baird
- Mettler-Toledo Earnings Call Highlights Resilient Growth Path
- Mettler-Toledo price target raised to $1,640 from $1,600 at BofA